We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sun Pharmaceutical has received a warning letter after an FDA inspection found several GMP issues related to the production of its lipid-lowering drug gemfibrozil.